News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,814 Results
Type
Article (9181)
Company Profile (56)
Press Release (276577)
Multimedia
Podcasts (4)
Webinars (5)
Section
Business (96503)
Career Advice (523)
Deals (17473)
Drug Delivery (17)
Drug Development (23990)
Employer Resources (35)
FDA (4494)
Job Trends (5364)
News (142670)
Policy (9462)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (739)
Accelerated approval (12)
Adcomms (4)
Allergies (19)
Alliances (20399)
ALS (52)
Alzheimer's disease (442)
Antibody-drug conjugate (ADC) (66)
Approvals (4618)
Artificial intelligence (183)
Autoimmune disease (40)
Automation (16)
Bankruptcy (115)
Best Places to Work (4100)
BIOSECURE Act (12)
Biosimilars (34)
Biotechnology (50)
Bladder cancer (51)
Brain cancer (17)
Breast cancer (231)
Cancer (1550)
Cardiovascular disease (82)
Career advice (456)
Career pathing (5)
CAR-T (92)
CDC (3)
Celiac Disease (1)
Cell therapy (258)
Cervical cancer (6)
Clinical research (20543)
Collaboration (617)
Compensation (423)
Complete response letters (10)
COVID-19 (636)
CRISPR (53)
C-suite (416)
Cystic fibrosis (36)
Data (1929)
Denatured (3)
Depression (28)
Diabetes (106)
Diagnostics (3345)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (80)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (53)
Earnings (46456)
Editorial (6)
Employer branding (6)
Employer resources (37)
Events (46869)
Executive appointments (515)
FDA (5404)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (491)
Gene editing (115)
Generative AI (13)
Gene therapy (184)
GLP-1 (187)
Government (780)
Guidances (217)
Healthcare (6487)
HIV (13)
Huntington's disease (10)
IgA nephropathy (23)
Immunology and inflammation (48)
Immuno-oncology (18)
Indications (27)
Infectious disease (680)
Inflammatory bowel disease (44)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (50)
Interviews (60)
IPO (8878)
IRA (3)
Job creations (1392)
Job search strategy (414)
JPM (6)
Kidney cancer (10)
Labor market (12)
Layoffs (124)
Leadership (5)
Legal (2836)
Liver cancer (28)
Longevity (5)
Lung cancer (200)
Lymphoma (97)
Machine learning (12)
Management (12)
Manufacturing (205)
MASH (58)
Medical device (4590)
Medtech (4605)
Mergers & acquisitions (9103)
Metabolic disorders (267)
Multiple sclerosis (26)
NASH (7)
Neurodegenerative disease (87)
Neuropsychiatric disorders (14)
Neuroscience (780)
NextGen: Class of 2026 (2112)
Non-profit (1061)
Now hiring (9)
Obesity (101)
Opinion (61)
Ovarian cancer (33)
Pain (46)
Pancreatic cancer (76)
Parkinson's disease (64)
Partnered (15)
Patents (91)
Patient recruitment (126)
Peanut (7)
People (29845)
Pharmaceutical (13)
Pharmacy benefit managers (2)
Phase 1 (6387)
Phase 2 (9104)
Phase 3 (7011)
Pipeline (2374)
Policy (35)
Postmarket research (690)
Preclinical (2726)
Press Release (69)
Prostate cancer (85)
Psychedelics (5)
Radiopharmaceuticals (131)
Rare diseases (261)
Real estate (2288)
Recruiting (9)
Regulatory (6917)
Reports (18)
Research institute (822)
Resumes & cover letters (71)
Rett syndrome (20)
RNA editing (4)
RSV (4)
Schizophrenia (60)
Series A (76)
Series B (69)
Service/supplier (2)
Sickle cell disease (33)
Special edition (1)
Spinal muscular atrophy (37)
Sponsored (8)
Startups (1417)
State (1)
Stomach cancer (1)
Supply chain (24)
Tariffs (7)
The Weekly (1)
Vaccines (137)
Venture capital (15)
Weight loss (34)
Women's health (8)
Date
Today (14)
Last 7 days (224)
Last 30 days (837)
Last 365 days (11350)
2026 (1474)
2025 (11602)
2024 (14273)
2023 (16776)
2022 (23065)
2021 (24810)
2020 (22304)
2019 (16507)
2018 (12634)
2017 (12709)
2016 (11861)
2015 (15038)
2014 (11578)
2013 (9378)
2012 (10077)
2011 (10520)
2010 (10241)
Location
Africa (255)
Alabama (29)
Alaska (3)
Arizona (103)
Arkansas (1)
Asia (14394)
Australia (2071)
California (4626)
Canada (1864)
China (247)
Colorado (175)
Connecticut (259)
Delaware (89)
Europe (31647)
Florida (674)
Georgia (80)
Hawaii (2)
Idaho (26)
Illinois (202)
India (27)
Indiana (156)
Iowa (16)
Japan (210)
Kansas (42)
Kentucky (20)
Louisiana (10)
Maine (56)
Maryland (464)
Massachusetts (3435)
Michigan (149)
Minnesota (240)
Mississippi (2)
Missouri (43)
Montana (19)
Nebraska (15)
Nevada (56)
New Hampshire (29)
New Jersey (1335)
New Mexico (15)
New York (1059)
North Carolina (666)
North Dakota (8)
Northern California (2364)
Ohio (139)
Oklahoma (8)
Oregon (6)
Pennsylvania (751)
Puerto Rico (3)
Rhode Island (21)
South America (355)
South Carolina (20)
Southern California (1724)
Tennessee (80)
Texas (703)
United States (15951)
Utah (148)
Virginia (98)
Washington D.C. (21)
Washington State (358)
West Virginia (2)
Wisconsin (80)
Wyoming (2)
285,814 Results for "quantum genomics corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
December 11, 2025
·
13 min read
Press Releases
Quantum BioPharma Ltd. Announces Corporate Updates
October 30, 2025
·
11 min read
Press Releases
Quantum BioPharma Announces Corporate Updates
September 29, 2025
·
5 min read
Press Releases
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
February 10, 2026
·
1 min read
Press Releases
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 13, 2026
February 15, 2026
·
1 min read
Press Releases
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
February 5, 2026
·
4 min read
Press Releases
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
February 1, 2026
·
8 min read
Press Releases
The World’s First Quantum AIDD Benchmark for FIC Drug Discovery Is Released: From 10% Success Rate to Deterministic Design
January 7, 2026
·
1 min read
Press Releases
QSimulate Announces New Financing and Latest Generation of Quantum Technology for Drug Discovery
November 21, 2025
·
2 min read
Press Releases
Quantum-Si Reports Third Quarter 2025 Financial Results
November 5, 2025
·
14 min read
1 of 28,582
Next
